|
|
|
|
By: Turner of Harris, et al. |
H.B. No. 2163 |
|
(Senate Sponsor - Uresti) |
|
|
(In the Senate - Received from the House May 18, 2009; |
|
May 19, 2009, read first time and referred to Committee on Health |
|
and Human Services; May 21, 2009, reported favorably by the |
|
following vote: Yeas 9, Nays 0; May 21, 2009, sent to printer.) |
|
|
A BILL TO BE ENTITLED
|
|
AN ACT
|
|
|
relating to a study regarding the provision of certain medications |
|
through the Medicaid vendor drug program to children younger than |
|
16 years of age. |
|
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
|
SECTION 1. Subchapter B, Chapter 531, Government Code, is |
|
amended by adding Section 531.0731 to read as follows: |
|
Sec. 531.0731. STUDY REGARDING THE PROVISION OF CERTAIN |
|
MEDICATION TO CHILDREN. (a) The commission shall conduct a study |
|
to determine the appropriateness and safety of providing |
|
antipsychotic or neuroleptic medication through the Medicaid |
|
vendor drug program to children younger than 16 years of age. |
|
(b) The study conducted under Subsection (a) must consider |
|
the following factors relevant to the appropriateness and safety of |
|
providing the medications to children: |
|
(1) the physical and psychological medical diagnosis |
|
of a child's condition; |
|
(2) whether the United States Food and Drug |
|
Administration has approved a medication for use by a child of a |
|
certain age; |
|
(3) whether a child has successfully taken a |
|
medication previously; |
|
(4) access to quality medical care for a child |
|
receiving benefits under the program; |
|
(5) the standard of care in the medical profession |
|
regarding the provision of such medications to a child; and |
|
(6) any other factor the commission considers |
|
relevant. |
|
(c) Not later than November 10, 2010, the executive |
|
commissioner shall submit a report containing the results of the |
|
study conducted under Subsection (a) to the governor, the |
|
lieutenant governor, the speaker of the house of representatives, |
|
and the chairs of the Senate Committee on Health and Human Services |
|
and the House Committee on Public Health. |
|
SECTION 2. This Act takes effect September 1, 2009. |
|
|
|
* * * * * |